Search Results - E. V. Pashchenko

  • Showing 1 - 6 results of 6
Refine Results
  1. 1
    Clinical, pathogenetic, and diagnostic features of heart failure in patients with coronary heart disease and thyrotoxicosis

    Clinical, pathogenetic, and diagnostic features of heart failure in patients with coronary heart disease and thyrotoxicosis by A. I. Chesnikova, E. V. Pashchenko, V. P. Terentyev, V. I. Kudinov

    Published 2019-11-01
    Get full text
    Article

    Save to List
    Saved in:
  2. 2
    CLINICAL SIGNIFICANCE OF DETERMINING THE LEVEL OF THE BRAIN NATRIURETIC PEPTIDE FOR THE DIAGNOSIS OF HEART FAILURE OF COMORBID PATIENTS WITH CORONARY HEART DISEASE AND THYROTOXICOSIS

    CLINICAL SIGNIFICANCE OF DETERMINING THE LEVEL OF THE BRAIN NATRIURETIC PEPTIDE FOR THE DIAGNOSIS OF HEART FAILURE OF COMORBID PATIENTS WITH CORONARY HEART DISEASE AND THYROTOXICOS... by E. V. Pashchenko, A. I. Chesnikova, V. I. Kudinov, V. P. Terent’ev

    Published 2017-09-01
    Get full text
    Article

    Save to List
    Saved in:
  3. 3
    Features of atherosclerotic lesions of the coronary arteries in patients with myocardial infarction and concomitant newly diagnosed hypothyroidism

    Features of atherosclerotic lesions of the coronary arteries in patients with myocardial infarction and concomitant newly diagnosed hypothyroidism by Yu. Yu. Gridneva, A. I. Chesnikova, A. V. Khripun, V. A. Safronenko, E. V. Pashchenko

    Published 2024-09-01
    Get full text
    Article

    Save to List
    Saved in:
  4. 4
    Calculation of the cut-off and evaluation of the dynamics of natriuretic peptide for optimization the management of comorbid patients with thyrototoxicosis and heart failure

    Calculation of the cut-off and evaluation of the dynamics of natriuretic peptide for optimization the management of comorbid patients with thyrototoxicosis and heart failure by E. V. Pashchenko, A. I. Chesnikova, V. I. Kudinov, V. P. Terentyev, O. E. Kolomatskaya

    Published 2018-12-01
    Get full text
    Article

    Save to List
    Saved in:
  5. 5
    STRUCTURAL AND FUNCTIONAL FEATURES OF LEFT VENTRICLE IN PATIENTS WITH HEART FAILURE, CORONARY HEART DISEASE AND THYROTOXICOSIS

    STRUCTURAL AND FUNCTIONAL FEATURES OF LEFT VENTRICLE IN PATIENTS WITH HEART FAILURE, CORONARY HEART DISEASE AND THYROTOXICOSIS by E. V. PASHCHENKO, A. I. CHESNIKOVA, V. P. TERENTYEV, V. I. KUDINOV, E. A. DEVETYAROVA

    Published 2018-10-01
    Get full text
    Article

    Save to List
    Saved in:
  6. 6
    CLINICAL CASE OF REPLACEMENT OF ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) BY SOLUBLE GUANYLATE CYCLASE STIMULATOR (RIOCIGUAT) IN THE PATIENT WITH PULMONARY ARTERIAL HYPERTENSION

    CLINICAL CASE OF REPLACEMENT OF ENDOTHELIN RECEPTOR ANTAGONIST (BOSENTAN) BY SOLUBLE GUANYLATE CYCLASE STIMULATOR (RIOCIGUAT) IN THE PATIENT WITH PULMONARY ARTERIAL HYPERTENSION by E. A. Devetyarova, A. A. Dyuzhikov, A. A. Dyuzhikova, S. V. Sobin, A. V. Sumin, E. V. Pashchenko

    Published 2018-06-01
    Get full text
    Article

    Save to List
    Saved in:

Search Tools: